GlassScriptPhysician profile
Mirle Girish
NPI 1205872876
$11,795.98
in general payments reported to CMS, 2019-2025
43 companies · $1,995 in 2025
The $1,995 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $199 · 2021: $699 · 2022: $2,387 · 2023: $1,788 · 2024: $4,384 · 2025: $1,995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,466 · Education: $2,701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,465.99 |
| Education | $2,700.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,769.22 | 2022-2024 | |
| Glaxosmithkline, LLC. | $1,421.39 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,361.52 | 2019-2025 | Airsupra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $737.62 | 2019-2025 | Ofev |
| Genzyme Corporation | $483.46 | 2020-2025 | |
| Mallinckrodt Hospital Products INC. | $330.00 | 2021-2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $329.03 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $299.09 | 2022-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $292.42 | 2021-2025 | Glassia |
| Baxter Healthcare | $264.83 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Mylan Specialty L.P. | $254.36 | 2019-2024 | Yupelri |
| Electromed, INC. | $245.83 | 2022-2025 | Smartvest |
| United Therapeutics Corporation | $232.91 | 2022-2025 | Tyvaso, Tyvaso |
| Actelion Pharmaceuticals US, INC. | $187.38 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Axsome Therapeutics, INC. | $157.51 | 2023-2024 | Sunosi |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $144.98 | 2023-2025 | |
| Philips North America LLC | $126.76 | 2022-2025 | Vest Therapy Und |
| Genentech USA, INC. | $124.93 | 2019-2021 | |
| Insmed, INC. | $119.05 | 2021-2025 | Arikayce |
| Inspire Medical Systems, INC. | $107.02 | 2023 | Inspire |
| Inogen, INC. | $91.76 | 2022-2024 | Inogen At Home Stationary Concentrator |
| Esperion Therapeutics, INC. | $81.27 | 2021 | |
| Harmony Biosciences LLC | $77.31 | 2022-2023 | Wakix |
| Verona Pharma, INC. | $50.10 | 2025 | Ohtuvayre |
| Daiichi Sankyo INC. | $46.55 | 2023-2024 | Enhertu |
| Ani Pharmaceuticals, INC. | $43.01 | 2023-2024 | Purified Cortrophin Gel |
| Lilly USA, LLC | $39.47 | 2025 | Zepbound |
| Viatris Specialty LLC | $34.95 | 2025 | Yupelri |
| Olympus America INC. | $32.37 | 2023-2025 | Olympus, Tecoflex, Ezdilate |
| Amgen INC. | $32.25 | 2023-2024 | Tezspire |
| Teva Pharmaceuticals USA, INC. | $30.38 | 2021 | |
| Sunovion Pharmaceuticals INC. | $28.99 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $26.91 | 2019 | |
| Vapotherm INC | $25.22 | 2022 | |
| Pfizer INC. | $24.24 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $19.56 | 2019 | |
| Zoll Respicardia, INC. | $18.43 | 2025 | Remede System |
| Lundbeck LLC | $18.34 | 2019 | |
| Amarin Pharma, INC. | $18.13 | 2020 | |
| Paratek Pharmaceuticals, INC. | $17.88 | 2022 | |
| Idorsia Pharmaceuticals US INC | $17.70 | 2023 | Quviviq |
| 3b Medical, INC. | $17.34 | 2025 | Luna |
| Circassia INC. | $14.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mirle Girish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.